Verify Opioid Treatment Agreement Measure

To achieve this objective and this measure, MIPS-capable physicians must use the capabilities and standards set for CEHRT at 45 CFR 170.315 (a) (10) (i), ii) and b) (3). Two new bonus measures have been included in the “Promoting Interoperability” (PI) category in the Merit-Based Incentive Payment System (MIPS) for 2019. The new measures are not necessary and do not contribute to the result of the measure, but they contribute to 5 bonus points each. Both bonus measures can be easily achieved by most painkillers. The measures are subject to the electronic prescribing objective and are as follows: for at least one single patient for whom a Schedule II opioid was prescribed electronically by the MIPS-compatible physician used by CEHRT during the delivery period, the doctor authorized to MIPS is attempting to determine the existence of a signed opioid treatment agreement, to determine the existence of a signed opioid treatment agreement and to include it in the patient`s electronic health record with CEHRT. The CMS proposed to reduce two measures to combat the opioid epidemic. Changes that reflect the category “Promotion of Interoperability” (PI) include the “PDMP” measure as an optional measure. You remove Verify Opioid Treatment Agreement. In 2019, to have rebalanced the category, which means that your PI grade weight would increase to 0 and your quality category would increase to 70, your group will need to have 100 percent of physicians who meet the CMS definition of a hospital doctor. By 2020, the requirement will decrease. If only 75 percent of your group must meet the hospital-based clinical definition to be eligible for a rebalancing of IP. For 2019, reports and evaluation in the IP category have been simplified.

There is a unique set of actions including new and existing IP performance class actions, organized as part of 4 objectives. Indicators are no longer classified as basic score or performance score ratios. Each indicator is evaluated by multiplying the power rate by the points available for the ratio. IP accounts for 25% of the total SCORE of MIPs. For at least one Schedule II opioid prescribed electronically with CEHRT (certified electronic health recording technology) during the period of service, the MIPS-compatible physician uses CEHRT data to conduct a consultation of a PDMP for the history of prescription drugs, unless this is prohibited and in accordance with applicable legislation. The number of unique patients on the denominator for which the MIPS-compatible physician intends to identify a signed opioid treatment agreement and, if identified, contains the agreement in CEHRT. Implementation of this measure requires a counter of at least one. In addition, the Agency is seeking advice on the adoption of two new measures regarding the clinical quality of opioids for the 2021 reference period: safe use of opioids, simultaneous prescribing and hospital damage, opioid-related adverse events. The number of unique patients for whom a Schedule II opioid was prescribed electronically by the compatible doctor WITH LETS during the service period and the total duration of Schedule II opioid prescriptions is at least 30 cumulative days, as indicated by the patient`s request on medication history and response during a 6-month retention period.